Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.

Ohguri, Takayuki; Imada, Hajime; Nomoto, Satoshi; Yahara, Katsuya; Hisaoka, Masanori; Hashimoto, Hiroshi; Tokura, Yoshiki; Nakamura, Katsumasa; Shioyama, Yoshiyuki; Honda, Hiroshi; Terashima, Hiromi; Moroi, Yoiichi; Furue, Masutaka; Korogi, Yukunori

Ohguri, Takayuki; Imada, Hajime; Nomoto, Satoshi; Yahara, Katsuya; Hisaoka, Masanori; Hashimoto, Hiroshi; Tokura, Yoshiki; Nakamura, Katsumasa; Shioyama, Yoshiyuki; Honda, Hiroshi; Terashima, Hiromi; Moroi, Yoiichi; Furue, Masutaka; Korogi, Yukunori.

Affiliation

Ohguri T; Department of Radiology, University of Occupational and Environmental Health, Kitakyushu, Japan. ogurieye@med.uoeh-u.ac.jp

Int J Radiat Oncol Biol Phys ; 61(5): 1446-53, 2005 Apr 01.

Article in En | MEDLINE | ID: mdl-15817349

Subject(s)

Antineoplastic Agents/therapeutic use; Head and Neck Neoplasms/therapy; Hemangiosarcoma/therapy; Immunotherapy/methods; Interleukin-2/therapeutic use; Scalp; Skin Neoplasms/therapy; Aged; Aged, 80 and over; Combined Modality Therapy; Disease-Free Survival; Female; Head and Neck Neoplasms/radiotherapy; Hemangiosarcoma/radiotherapy; Humans; Male; Middle Aged; Radiotherapy Dosage; Recombinant Proteins/therapeutic use; Retrospective Studies; Skin Neoplasms/radiotherapy

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Scalp / Skin Neoplasms / Interleukin-2 / Head and Neck Neoplasms / Immunotherapy / Hemangiosarcoma / Antineoplastic Agents Type of study: Evaluation_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2005 Type: Article

Search on Google

XML

PubMed Links